FDA Inspection 1036196 — Admix Pharma Laboratories, LLC
The FDA completed an inspection of Admix Pharma Laboratories, LLC on Dec 11, 2017 in South Plainfield, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 11, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- South Plainfield, NJ (United States)